Temple, Miriam P.

HRN: 26-82-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
CEFUROXIME 1.5GM (VIAL)
04/09/2025
04/09/2025
IV
1.5 Gms
PTOR
Stat CS
Waiting Final Action 
04/09/2025
CEFUROXIME 1.5GM (VIAL)
04/09/2025
04/15/2025
IV
Pi
1.5g
Nka
Waiting Final Action 
04/10/2025
CEFUROXIME 500MG (TAB)
04/10/2025
04/17/2025
PO
500mg
BID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: